OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 55 citing articles:

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Gavin Y. Oudit, Kaiming Wang, Anissa Viveiros, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 906-922
Open Access | Times Cited: 80

Genetic diversity and evolutionary convergence of cryptic SARS- CoV-2 lineages detected via wastewater sequencing
Devon A. Gregory, Mónica Trujillo, Clayton Rushford, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 10, pp. e1010636-e1010636
Open Access | Times Cited: 54

Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
Vanessa Monteil, Brett Eaton, Elena Postnikova, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 46

Molecular simulations of complex carbohydrates and glycoconjugates
Elisa Fadda
Current Opinion in Chemical Biology (2022) Vol. 69, pp. 102175-102175
Open Access | Times Cited: 45

Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant
Wei Zhang, Ke Shi, Qibin Geng, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 44
Open Access | Times Cited: 43

Impaired immune response drives age-dependent severity of COVID-19
Julius Beer, Stefania Crotta, Angele Breithaupt, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 12
Open Access | Times Cited: 42

Tissue‐resident memory T cells and lung immunopathology
In Su Cheon, Young Min Son, Jie Sun
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 63-83
Open Access | Times Cited: 36

Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein
Dhiraj Mannar, James W. Saville, Chad Poloni, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10

Cyclophilin–CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8
Gábor Tajti, Laura Gebetsberger, Gregor Pamlitschka, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
Rong Zhu, Daniel Canena, Mateusz Sikora, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
Robert H. Shoemaker, Reynold A. Panettieri, Steven K. Libutti, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271066-e0271066
Open Access | Times Cited: 27

Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
Jerneja Kladnik, Ana Dolinar, Jakob Kljun, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2158-2168
Open Access | Times Cited: 23

Structural analysis of receptor engagement and antigenic drift within the BA.2 spike protein
James W. Saville, Dhiraj Mannar, Xing Zhu, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111964-111964
Open Access | Times Cited: 15

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
Paul J. Baker, Eduardo P. Amaral, Ehydel Castro, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14

Neutrophil Extracellular Traps in Cardiovascular and Aortic Disease: A Narrative Review on Molecular Mechanisms and Therapeutic Targeting
Nahla Ibrahim, Wolf Eilenberg, Christoph Neumayer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3983-3983
Open Access | Times Cited: 6

IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques
Christine E Nelson, Christine E Nelson, Christine E Nelson, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012339-e1012339
Open Access | Times Cited: 6

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
Daniel Batlle, Vanessa Monteil, Elena Garreta, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1837-1839
Open Access | Times Cited: 22

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13

A highly susceptible hACE2-transgenic mouse model for SARS-CoV-2 research
Gang Liu, Min Zhang, Baolei Wu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4

Interferons—Implications in the Immune Response to Respiratory Viruses
Harrison C. Bergeron, Matthew R. Hansen, Ralph A. Tripp
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2179-2179
Open Access | Times Cited: 10

Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections
Vanessa Monteil, Hyesoo Kwon, Lijo John, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10

The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients
Hazan Karadeniz, Aslıhan Avanoğlu Güler, Hasan Selçuk Özger, et al.
Biomarker Insights (2022) Vol. 17
Open Access | Times Cited: 16

Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection
Ashleigh N. Riegler, Paul V. Benson, Kenneth D. Long, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9

The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferons
Luz E. Cabrera, Suvi T. Jokiranta, Sanna Mäki, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012368-e1012368
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top